In Vivo Imaging of Tumor Physiological, Metabolic, and Redox Changes in Response to the Anti-Angiogenic Agent Sunitinib: Longitudinal Assessment to Identify Transient Vascular Renormalization-Reference-Cited by-同舟云学术

In Vivo Imaging of Tumor Physiological, Metabolic, and Redox Changes in Response to the Anti-Angiogenic Agent Sunitinib: Longitudinal Assessment to Identify Transient Vascular Renormalization

Published:2014-09-10 Issue:8 Volume:21 Page:1145-1155
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

Matsumoto Shingo¹,Saito Keita¹,Takakusagi Yoichi¹,Matsuo Masayuki¹,Munasinghe Jeeva P.²,Morris Herman D.²,Lizak Martin J.²,Merkle Hellmut³,Yasukawa Keiji⁴,Devasahayam Nallathamby¹,Suburamanian Sankaran¹,Mitchell James B.¹,Krishna Murali C.¹

Affiliation:

1. Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

2. Mouse Imaging Facility, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, Maryland.

3. Laboratory for Functional and Molecular Imaging, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, Maryland.

4. Department of Bio-functional Science, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/ars.2013.5725

Reference41 articles.

1. Mechanism of Reoxygenation after Antiangiogenic Therapy Using SU5416 and Its Importance for Guiding Combined Antitumor Therapy

2. Decrease in Tumor Cell Oxygen Consumption after Treatment with Vandetanib (ZACTIMA™; ZD6474) and its Effect on Response to Radiotherapy

3. Imaging Key Biomarkers of Tumor Angiogenesis

4. AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature and Inhibition of Homologous Recombination DNA Repair;Antioxidants & Redox Signaling;2023-09-01

2. Effective low-dose Anlotinib induces long-term tumor vascular normalization and improves anti-PD-1 therapy;Frontiers in Immunology;2022-08-03

3. PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study;Neoplasia;2022-08

4. The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia;Frontiers in Pharmacology;2022-07-15

5. Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature and Inhibition of Homologous Recombination DNA Repair;2022-07-05